Hydrocortisone Sodium Succinate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Hydrocortisone Sodium Succinate Injection (injection) from Hospira, Inc., a Pfizer Company with status Resolved. The shortage was first posted on 03/24/2023.
Shortage Details
- Status
- Resolved
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0009-0013-05
- Dosage Form
- Injection
- Presentation
- Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-05)
- Initial Posting
- 03/24/2023
- Revised Date